Valuation: JBCHEMICAPAR

Market Cap 39TCr 405.73Cr 352.7Cr 328.28Cr 301.41Cr 569.18Cr 578Cr 3.87TCr 1.52TCr 19TCr 1.52TCr 1.49TCr 65TCr P/E 2027 *
43.3x
P/E 2028 * 33x
Enterprise Value 39TCr 405.73Cr 352.7Cr 328.28Cr 301.41Cr 569.18Cr 578Cr 3.87TCr 1.52TCr 19TCr 1.52TCr 1.49TCr 65TCr EV / Sales 2027 *
8.14x
EV / Sales 2028 * 7.12x
Free-Float
-
Yield 2027 *
0.72%
Yield 2028 * 0.86%
1 day-3.87%
Current month+4.92%
1 month+4.92%
3 months+17.89%
6 months+28.85%
Current year+32.38%
1 month 2,288.3
Extreme 2288.3
2,525.5
Current year 1,775.8
Extreme 1775.8
2,525.5
1 year 1,638.5
Extreme 1638.5
2,525.5
3 years 1,232.15
Extreme 1232.15
2,525.5
5 years 671.1
Extreme 671.1
2,525.5
10 years 119.98
Extreme 119.975
2,525.5

Financials

2027 *2028 *
Net sales 4.76TCr 50Cr 43Cr 40Cr 37Cr 70Cr 71Cr 475.62Cr 186.67Cr 2.37TCr 187.28Cr 183.17Cr 7.95TCr 5.44TCr 57Cr 50Cr 46Cr 42Cr 80Cr 81Cr 543.6Cr 213.35Cr 2.71TCr 214.05Cr 209.35Cr 9.08TCr
Net income 899.73Cr 9.43Cr 8.19Cr 7.63Cr 7Cr 13Cr 13Cr 90Cr 35Cr 447.93Cr 35Cr 35Cr 1.5TCr 1.19TCr 12Cr 11Cr 10Cr 9.22Cr 17Cr 18Cr 118.43Cr 46Cr 590.14Cr 47Cr 46Cr 1.98TCr
Net Debt - -
Logo JBCHEMICAPAR
J.B. Chemicals & Pharmaceuticals Limited is an India-based pharmaceutical company. The Company specializes in gastroenterology, hypertension and dermatology. It is also focused on other therapeutic categories like nephrology, respiratory, virology, diabetes, and nicotine replacement therapy (NRT). The Company is engaged in the business of manufacturing and marketing of a diverse range of pharmaceutical formulations, herbal remedies and active pharmaceutical ingredients (APIs). Its brands include Nicardia, Cilacar, Rantac, Metrogyl, and Cilacar-T. It specializes in manufacturing medicated and herbal lozenges. It produces hard-candy lozenges, soft-center lozenges and powder-filled lozenges for varied medical needs. Its API products include Diclofenac Sodium, Diclofenac Diethylamine, Diclofenac Acid, Nifedipine, and others. It maintains a direct presence in Russia and South Africa, while leveraging distributor partnerships across the United States, Asia, Africa, and Latin America.
Employees
5,602
Sector
-
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
2,412.25INR
Average target price
2,307.12INR
Spread / Average Target
-4.36%

Quarterly revenue - Rate of surprise